MARKSANS PHARMA
Back to Cashflow Statement
|
MARKSANS PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹230 Cr | ₹237 Cr | ₹99 Cr | ₹179 Cr | ₹233 Cr |
What is the latest Cash Flow from Operating Activities ratio of MARKSANS PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹230 Cr |
Mar2023 | ₹237 Cr |
Mar2022 | ₹99 Cr |
Mar2021 | ₹179 Cr |
Mar2020 | ₹233 Cr |
How is Cash Flow from Operating Activities of MARKSANS PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹230 Cr | -2.95 | |
Mar2023 | ₹237 Cr | 139.19 | |
Mar2022 | ₹99 Cr | -44.42 | |
Mar2021 | ₹179 Cr | -23.46 | |
Mar2020 | ₹233 Cr | - |
Compare Cash Flow from Operating Activities of peers of MARKSANS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MARKSANS PHARMA | ₹13,761.4 Cr | -2.7% | -1.7% | 97.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹433,920.0 Cr | -0.1% | 1.7% | 45.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,160.0 Cr | -0.1% | -2.2% | 56.9% | Stock Analytics | |
CIPLA | ₹118,917.0 Cr | 1.7% | 0.5% | 23.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,017.0 Cr | 5.7% | 12.4% | 18.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,997.1 Cr | -1.4% | 3.1% | 44.8% | Stock Analytics |
MARKSANS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MARKSANS PHARMA | -2.7% |
-1.7% |
97.1% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses